EXC 1003 FF-2016-11 - Effects of newly generated, peripherally-selective, anti-inflammatory kappa-opioid receptor agonists in the treatment of progressive CNS inflammation and neurodegeneration
Basic data for this project
Type of project: Subproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster: 01/07/2016 - 30/06/2018 | 1st Funding period
Description
Multiple Sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system (CNS). Is a therapy, which is restricted to the periphery (i.e. to sites where pathogenic effector cells are developing), sufficient to down-regulate inflammation in the CNS? Which role might agonists of the κ(kappa) opioid receptor, a subtype of opioid receptors, play in this scenario? These are questions, which will be addressed by researchers from different disciplines in this CiM project.
Keywords: inflammatory; receptor; neurodegeneration
Website of the project: http://www.uni-muenster.de/Cells-in-Motion/research/projects/flexible-funds/FF-2016-11.php
Funder / funding scheme:
- DFG - Cluster of Excellence (EXC)
Project management at the University of Münster
| Loser, Karin | Clinic for Dermatology |
| Ständer, Sonja | Clinic for Dermatology |
| Wünsch, Bernhard | Professur für Pharmazeutische Chemie (Prof. Wünsch) |
Applicants from the University of Münster
| Loser, Karin | Clinic for Dermatology |
| Ständer, Sonja | Clinic for Dermatology |
| Wünsch, Bernhard | Professur für Pharmazeutische Chemie (Prof. Wünsch) |